Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Pulmonary Disease

Answer 4
  1. Add a long-acting ß-agonist such as salmeterol or formoterol to his fluticasone therapy. Oral cortico-steroids such as prednisone are usually reserved for patients with acute exacerbations of asthma symptoms and PEFs below 50% of predicted. Some patients with exacerbations and PEFs between 50% and 70% are treated with prednisone. This patient has moderate, persistent asthma. Increasing the dose of his inhaled corticosteroid or adding a long-acting ß-agonist are both acceptable treatment options. Since long-term treatment with high-dose inhaled corticosteroids may lead to complications, adding a long-acting bronchodilator may be preferred.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj